Zevra Therapeutics Inc (ZVRA)
4.55
-0.10
(-2.15%)
USD |
NASDAQ |
Jun 17, 16:00
4.56
+0.01
(+0.22%)
After-Hours: 20:00
Zevra Therapeutics Shareholders Equity (Quarterly): 48.82M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 48.82M |
December 31, 2023 | 61.86M |
September 30, 2023 | 67.47M |
June 30, 2023 | 68.50M |
March 31, 2023 | 71.40M |
December 31, 2022 | 75.12M |
September 30, 2022 | 93.79M |
June 30, 2022 | 99.23M |
March 31, 2022 | 121.50M |
December 31, 2021 | 127.12M |
September 30, 2021 | 131.74M |
June 30, 2021 | 130.66M |
March 31, 2021 | 84.25M |
December 31, 2020 | -66.41M |
September 30, 2020 | -62.33M |
June 30, 2020 | -62.86M |
March 31, 2020 | -68.68M |
December 31, 2019 | -74.46M |
September 30, 2019 | -70.62M |
Date | Value |
---|---|
June 30, 2019 | -81.55M |
March 31, 2019 | -74.84M |
December 31, 2018 | -66.57M |
September 30, 2018 | -95.34M |
June 30, 2018 | -83.54M |
March 31, 2018 | -79.68M |
December 31, 2017 | -57.52M |
September 30, 2017 | -48.10M |
June 30, 2017 | -39.28M |
March 31, 2017 | -33.93M |
December 31, 2016 | -18.70M |
September 30, 2016 | -9.802M |
June 30, 2016 | 0.333M |
March 31, 2016 | -11.48M |
December 31, 2015 | -10.12M |
September 30, 2015 | -5.746M |
June 30, 2015 | 3.463M |
March 31, 2015 | -54.35M |
December 31, 2014 | -48.51M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-81.55M
Minimum
Jun 2019
131.74M
Maximum
Sep 2021
34.73M
Average
67.98M
Median
Shareholders Equity (Quarterly) Benchmarks
Dare Bioscience Inc | -11.00M |
ENDRA Life Sciences Inc | 3.698M |
OptiNose Inc | -99.22M |
Kodiak Sciences Inc | 241.19M |
INmune Bio Inc | 29.02M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 151.28M |
Total Liabilities (Quarterly) | 102.46M |
Debt to Equity Ratio | 0.8808 |
Current Ratio | 2.103 |
Net Debt Paydown Yield | -2.49% |